» Articles » PMID: 30302129

Combined Effect of Glycemic and Blood Pressure Control on Diabetic Retinopathy Among Chinese with Type-2 Diabetes Mellitus

Overview
Publisher Biomed Central
Specialty Endocrinology
Date 2018 Oct 11
PMID 30302129
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Background: To explore the associations of glycemic and blood pressure (BP) control with diabetic retinopathy (DR), with special focus on whether different combinations of categories of these two interventions are additive.

Methods: A community-based survey including 913 patients with known type-2 diabetes mellitus (T2DM) was conducted in Suzhou, China. Retinal photographs were graded for the presence of DR using the Airlie House classification system. BP and blood hemoglobin A1c (HbA1C) levels were measured by standardized protocols. Binary logistic regression models were established to examine the associations of risk factors with DR.

Results: The overall prevalence of any DR was 18.0% [95% confidence interval (95% CI) 15.5-20.6%] in this population. Stratified by conventional control thresholds, lower levels of either systolic blood pressure (SBP, < 140 mmHg) or HbA1C (< 7.0%) were not significantly associated with decreased susceptibility to DR, while patients simultaneously with lower HbA1C and SBP levels demonstrated 43% reduced likelihood of developing DR [adjusted odds ratio (OR) = 0.57, 95% CI 0.33-0.99, = 0.045)], comparing with those with both higher levels of HbA1C (≥ 7.0%) and SBP (≥ 140 mmHg). Meanwhile, the group achieved intensive HbA1C (< 6.5%) and SBP (< 120 mmHg) control goals were found to have the smallest OR, but failed in yielding statistical significance (P = 0.10).

Conclusions: In this community-based DR screening study of Chinese adults with T2DM, combination but not individual of lower SBP (< 140 mmHg) and HbA1C (< 7.0%) levels, were suggested to be associated with a significantly reduced likelihood of having DR.

Citing Articles

Scoring and validation of a simple model for predicting diabetic retinopathy in patients with type 2 diabetes based on a meta-analysis approach of 21 cohorts.

Guo H, Han F, Qu J, Pan C, Sun B, Chen L Ann Med. 2024; 56(1):2413920.

PMID: 39392052 PMC: 11485693. DOI: 10.1080/07853890.2024.2413920.


The causal effect of hypertension, intraocular pressure, and diabetic retinopathy: a Mendelian randomization study.

Wang X, Zhang X, Liu Y, Zheng X, Su M, Sun X Front Endocrinol (Lausanne). 2024; 15:1304512.

PMID: 38379860 PMC: 10877050. DOI: 10.3389/fendo.2024.1304512.


Development and evaluation of a risk prediction model for diabetes mellitus type 2 patients with vision-threatening diabetic retinopathy.

Gong D, Fang L, Cai Y, Chong I, Guo J, Yan Z Front Endocrinol (Lausanne). 2023; 14:1244601.

PMID: 37693352 PMC: 10484608. DOI: 10.3389/fendo.2023.1244601.


Systolic and Diastolic Blood Pressure Are Independent Risk Factors for Diabetic Retinopathy in Patients with Type 2 Diabetes.

Bulum T, Tomic M, Vrabec R, Brkljacic N, Ljubic S Biomedicines. 2023; 11(8).

PMID: 37626738 PMC: 10452473. DOI: 10.3390/biomedicines11082242.


Severity of diabetic retinopathy and its relationship with age at onset of diabetes mellitus in India: A multicentric study.

Parameswarappa D, Rajalakshmi R, Mohamed A, Kavya S, Munirathnam H, Manayath G Indian J Ophthalmol. 2021; 69(11):3255-3261.

PMID: 34708783 PMC: 8725142. DOI: 10.4103/ijo.IJO_1459_21.

References
1.
. Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators. Lancet. 2000; 355(9200):253-9. View

2.
Kempen J, OColmain B, Leske M, Haffner S, Klein R, Moss S . The prevalence of diabetic retinopathy among adults in the United States. Arch Ophthalmol. 2004; 122(4):552-63. DOI: 10.1001/archopht.122.4.552. View

3.
Rudnisky C, Wong B, Virani H, Tennant M . Risk factors for progression of diabetic retinopathy in Alberta First Nations communities. Can J Ophthalmol. 2017; 52 Suppl 1:S19-S29. DOI: 10.1016/j.jcjo.2017.09.023. View

4.
Song P, Yu J, Chan K, Theodoratou E, Rudan I . Prevalence, risk factors and burden of diabetic retinopathy in China: a systematic review and meta-analysis. J Glob Health. 2018; 8(1):010803. PMC: 5997368. DOI: 10.7189/jogh.08.010803. View

5.
Xie X, Xu L, Jonas J, Wang Y . Prevalence of diabetic retinopathy among subjects with known diabetes in China: the Beijing Eye Study. Eur J Ophthalmol. 2009; 19(1):91-9. DOI: 10.1177/112067210901900114. View